ANTIOXIDANTS & REDOX SIGNALING

抗氧化剂和氧化还原信号(ARS)是致力于了解氧化还原原理控制健康和疾病的领先杂志。这本杂志提供和探索了氧化还原疗法的重要和不断扩大的世界的关键方面-遗传，药理和营养。前沿研究领域包括结构生物学、干细胞、再生医学、表观遗传学、影像学、临床结果、预防和治疗营养等。ARS已经扩展到在一本杂志中创建两个独特的焦点:ARS发现和ARS治疗。ARS的发现(24期)出版了基础研究和应用研究的最高水平的突破。ARS Therapeutics(12期)是第一本此类出版物，通过展示氧化还原科学改变健康结果的潜力，将有助于增强氧化还原生物学的整个领域。ARS覆盖范围包括:ROS / RNS信使气体传感器的信号缺氧和组织氧合微原核系统植物生物学课程ARS由主编Chandan K. Sen博士、俄亥俄州立大学Wexner医学中心和其他主要研究人员领导。查看整个编辑委员会。听众:细胞生物学家，分子生物学家，生物化学家，医学研究人员，营养学家等等。ARS在验收后72小时内提供“即时在线”出版物。第一次决定的平均时间:18天平均分类时间:48小时索引/抽象:MEDLINE;PubMed;公共医学中心;当前内容?/生命科学;科学引文索引扩展;生物化学与生物物理学引文索引;生物提取;生物预览;期刊引用报告/科学版;EMBASE /摘要》;EMBiology;斯高帕斯;化学文摘;ProQuest数据库

Antioxidants & Redox Signaling (ARS) is the leading journal dedicated to the understanding of redox principles governing health and disease. This Journal provides and explores key aspects of the important and expanding world of redox-based therapeutics—genetic, pharmacological, and nutritional. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.ARS coverage includes:ROS/RNS as messengersGaseous signal transducersHypoxia and tissue oxygenationmicroRNAProkaryotic systemsLessons from plant biologyARS is under the editorial leadership of Editor-in-Chief Chandan K. Sen, PhD, The Ohio State University Wexner Medical Center, and other leading investigators. View the entire editorial board.Audience: Cell biologists, molecular biologists, biochemists, medical researchers, and nutritionists, among others.ARS provides "Instant Online" publication 72 hours after acceptance. Average time to first decision: 18 days Average time to triage decision: 48 hoursIndexed/Abstracted in:MEDLINE; PubMed; PubMed Central; Current Contents?/Life Sciences; Science Citation Index Expanded;Science Citation Index?; Biochemistry & Biophysics Citation Index?; Biological Abstracts; BIOSIS Previews;Journal Citation Reports/Science Edition; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts;ProQuest databases